• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢他啶的亚最低抑菌浓度可抑制铜绿假单胞菌生物膜的形成。

Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.

作者信息

Otani Satoshi, Hiramatsu Kazufumi, Hashinaga Kazuhiko, Komiya Kosaku, Umeki Kenji, Kishi Kenji, Kadota Jun-Ichi

机构信息

Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, Yufu, Oita, 879-5593, Japan.

Department of Medical Safety Management, Oita University Faculty of Medicine, Yufu, Oita, 879-5593, Japan.

出版信息

J Infect Chemother. 2018 Jun;24(6):428-433. doi: 10.1016/j.jiac.2018.01.007. Epub 2018 Feb 12.

DOI:10.1016/j.jiac.2018.01.007
PMID:29449129
Abstract

Pseudomonas aeruginosa exhibits the biofilm mode of growth and causes chronic as well as acute infections in humans. Several reports have shown that the treatments with sub-minimum inhibitory concentrations (sub-MICs) of antimicrobial agents influence biofilm formation by P. aeruginosa. The antibiotic ceftazidime (CAZ) is used to treat P. aeruginosa infections, but few studies have examined the effects of β-lactams on biofilm formation by P. aeruginosa. In this study, we investigated the role of sub-MICs of CAZ in the formation of P. aeruginosa biofilms. 1/4 × MIC CAZ reduced the biofilm volume of P. aeruginosa PAO1, as quantified by crystal violet staining. The formation of P. aeruginosa PAO1 biofilms treated with 1/4 × MIC CAZ were observed by confocal laser scanning microscopy. They were more heterogeneous than the PAO1 biofilms without CAZ treatment. Furthermore, sub-MICs of CAZ inhibited the twitching motility, which played an important role in mature biofilm formation. 1/4 × MIC CAZ also reduced the gene expressions of lecA, lecB, pel and psl, which mediate the adhesion and polysaccharide matrix synthesis of P. aeruginosa. These effects suggest that sub-MICs of CAZ may affect a number of stages of biofilm formation. Investigating the effects of sub-MIC antibiotics on targeted bacterial biofilm may lead to the development of future antibiotic treatment modalities.

摘要

铜绿假单胞菌呈现生物膜生长模式,可导致人类慢性和急性感染。多项报告表明,用低于最低抑菌浓度(亚 MIC)的抗菌剂处理会影响铜绿假单胞菌的生物膜形成。抗生素头孢他啶(CAZ)用于治疗铜绿假单胞菌感染,但很少有研究考察β-内酰胺类药物对铜绿假单胞菌生物膜形成的影响。在本研究中,我们调查了 CAZ 的亚 MIC 在铜绿假单胞菌生物膜形成中的作用。通过结晶紫染色定量分析,1/4×MIC 的 CAZ 降低了铜绿假单胞菌 PAO1 的生物膜体积。用共聚焦激光扫描显微镜观察了经 1/4×MIC CAZ 处理的铜绿假单胞菌 PAO1 生物膜的形成。它们比未用 CAZ 处理的 PAO1 生物膜更具异质性。此外,CAZ 的亚 MIC 抑制了在成熟生物膜形成中起重要作用的颤动运动。1/4×MIC 的 CAZ 还降低了介导铜绿假单胞菌黏附及多糖基质合成的 lecA、lecB、pel 和 psl 的基因表达。这些效应表明,CAZ 的亚 MIC 可能影响生物膜形成的多个阶段。研究亚 MIC 抗生素对靶向细菌生物膜的影响可能会带来未来抗生素治疗方式的发展。

相似文献

1
Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.头孢他啶的亚最低抑菌浓度可抑制铜绿假单胞菌生物膜的形成。
J Infect Chemother. 2018 Jun;24(6):428-433. doi: 10.1016/j.jiac.2018.01.007. Epub 2018 Feb 12.
2
Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.姜黄素亚抑菌浓度与头孢他啶和环丙沙星对铜绿假单胞菌群体感应相关基因及毒力特性的协同活性。
World J Microbiol Biotechnol. 2017 Mar;33(3):50. doi: 10.1007/s11274-016-2195-0. Epub 2017 Feb 10.
3
Phenotypic characterization of multidrug-resistant Pseudomonas aeruginosa strains isolated from pediatric patients associated to biofilm formation.从与生物膜形成相关的儿科患者中分离出的多药耐药铜绿假单胞菌菌株的表型特征。
Microbiol Res. 2015 Mar;172:68-78. doi: 10.1016/j.micres.2014.11.005. Epub 2014 Dec 5.
4
In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm.单独和联合黏菌素持续头孢他啶输注对铜绿假单胞菌生物膜的体外药代动力学/药效学研究。
Int J Antimicrob Agents. 2021 Feb;57(2):106246. doi: 10.1016/j.ijantimicag.2020.106246. Epub 2020 Nov 28.
5
Fucoidan-Stabilized Gold Nanoparticle-Mediated Biofilm Inhibition, Attenuation of Virulence and Motility Properties in PAO1.岩藻聚糖硫酸酯稳定的金纳米颗粒介导的生物膜抑制、毒力和运动性减弱在 PAO1 中的作用。
Mar Drugs. 2019 Apr 3;17(4):208. doi: 10.3390/md17040208.
6
The effect of the sub-minimal inhibitory concentration and the concentrations within resistant mutation window of ciprofloxacin on MIC, swimming motility and biofilm formation of Pseudomonas aeruginosa.左氧氟沙星亚最小抑菌浓度及耐药突变窗浓度对铜绿假单胞菌 MIC、泳动能力和生物膜形成的影响。
Microb Pathog. 2019 Dec;137:103765. doi: 10.1016/j.micpath.2019.103765. Epub 2019 Oct 2.
7
Increased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.阿奇霉素与头孢他啶联合用药对输尿管支架感染动物模型中铜绿假单胞菌生物膜的治疗效果增强。
BMC Microbiol. 2016 Jun 24;16(1):124. doi: 10.1186/s12866-016-0744-1.
8
Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.黄芩苷在小鼠腹腔植入感染模型中抑制生物膜形成,减弱群体感应控制的毒力并增强铜绿假单胞菌清除能力。
PLoS One. 2017 Apr 28;12(4):e0176883. doi: 10.1371/journal.pone.0176883. eCollection 2017.
9
Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.CXA-101 对铜绿假单胞菌 PAO1 慢性呼吸道感染表型的抗生物膜和耐药抑制活性。
J Antimicrob Chemother. 2010 Jul;65(7):1399-404. doi: 10.1093/jac/dkq143. Epub 2010 Apr 30.
10
Sub-minimum inhibitory concentration ceftazidime inhibits biofilm formation by influencing the levels of the gene and extracellular indole.亚最低抑菌浓度的头孢他啶通过影响基因和细胞外吲哚的水平来抑制生物膜形成。
J Chemother. 2020 Feb;32(1):7-14. doi: 10.1080/1120009X.2019.1678913. Epub 2019 Oct 21.

引用本文的文献

1
Biofilm inhibition of multidrug-resistant Pseudomonas aeruginosa using green-synthesized silver nanoparticles and colistin.使用绿色合成银纳米颗粒和黏菌素对多重耐药铜绿假单胞菌生物膜的抑制作用
Sci Rep. 2025 Apr 29;15(1):14993. doi: 10.1038/s41598-025-00005-6.
2
Effects of Anti-Pseudomonal Agents, Individually and in Combination, With or Without Clarithromycin, on Growth and Biofilm Formation by Antibiotic-Susceptible and -Resistant Strains of and the Impact of Exposure to Cigarette Smoke Condensate.抗假单胞菌药物单独及联合使用(无论有无克拉霉素)对敏感及耐药菌株生长和生物膜形成的影响以及接触香烟烟雾冷凝物的影响
Antibiotics (Basel). 2025 Mar 19;14(3):325. doi: 10.3390/antibiotics14030325.
3
Ceftazidime/Tobramycin Co-Loaded Chitosan-Coated Zein Nanoparticles against Antibiotic-Resistant and Biofilm-Producing and .
头孢他啶/妥布霉素共载壳聚糖包被玉米醇溶蛋白纳米粒对抗抗生素耐药及生物膜产生菌和……(原文最后似乎不完整)
Pharmaceuticals (Basel). 2024 Feb 29;17(3):320. doi: 10.3390/ph17030320.
4
Issues beyond resistance: inadequate antibiotic therapy and bacterial hypervirulence.耐药性之外的问题:抗生素治疗不足与细菌超毒力
FEMS Microbes. 2020 Oct 17;1(1):xtaa004. doi: 10.1093/femsmc/xtaa004. eCollection 2020 Sep.
5
Effects of Sub-Minimum Inhibitory Concentrations of Gentamicin on Alginate Produced by Clinical Isolates of .庆大霉素亚最小抑菌浓度对临床分离株产生的藻酸盐的影响 。 需注意,你提供的原文最后“. ”这里表述不完整,可能影响对完整意思的理解。
Adv Biomed Res. 2023 Apr 25;12:94. doi: 10.4103/abr.abr_389_21. eCollection 2023.
6
Recent Advances in the Control of Clinically Important Biofilms.临床重要生物膜控制的最新进展。
Int J Mol Sci. 2022 Aug 23;23(17):9526. doi: 10.3390/ijms23179526.
7
Antibacterial and anti-virulence effects of furazolidone on Trueperella pyogenes and Pseudomonas aeruginosa.呋喃唑酮对酿脓链球菌和铜绿假单胞菌的抗菌和抗毒力作用。
BMC Vet Res. 2022 Mar 24;18(1):114. doi: 10.1186/s12917-022-03216-5.
8
Different effects of sub-minimum inhibitory concentrations of gentamicin on the expression of genes involved in alginate production and biofilm formation of .庆大霉素亚最小抑菌浓度对藻酸盐产生及生物膜形成相关基因表达的不同影响 。 需注意,原文中“. ”部分内容缺失,翻译可能不太完整准确,你可补充完整原文以便我给出更精准译文。
Iran J Microbiol. 2021 Dec;13(6):808-816. doi: 10.18502/ijm.v13i6.8085.
9
In vitro activities of cellulase and ceftazidime, alone and in combination against Pseudomonas aeruginosa biofilms.纤维素酶和头孢他啶单独及联合对铜绿假单胞菌生物膜的体外活性。
BMC Microbiol. 2021 Dec 16;21(1):347. doi: 10.1186/s12866-021-02411-y.
10
Sub-Inhibitory Antibiotic Exposure and Virulence in .亚抑菌浓度抗生素暴露与……中的毒力
Antibiotics (Basel). 2021 Nov 13;10(11):1393. doi: 10.3390/antibiotics10111393.